Prenatal glucocorticoids and the programming of adult disease

Birth, Distress and Disease: Placental-Brain Interactions

Volumn 9780521831482, Issue , 2005, Pages 142-182

  Seckl, Jonathan R ^a   Drake, Amanda J ^a   Holmes, Megan C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42549155549     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545658.007     Document Type: Chapter

References (251)

1. Albiston, A. L., Obeyesekere, V. R., Smith, R. E. and Krozowski, Z. S. (1994). Cloning and tissue distribution of the human 11_-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol., 105(2), R11-17.
2. Antonow-Schlorke, I., Schwab, M., Li, C. and Nathanielsz, P. W. (2003). Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J. Physiol. London, 547(1), 117-23.
3. Arai, Y. and Gorski, R. A. (1968). Critical exposure time for androgenization of the developing hypothalamus in the female rat. Endocrinology, 82, 1010-14.
4. Baird, J., Osmond, C., MacGregor, A. et al. (2001). Testing the fetal origins hypothesis in twins: the Birmingham twin study. Diabetologia, 44, 33-9.
5. Barker, D. J. P. (1991). Fetal and Infant Origins of Adult Disease, London: BMJ.
6. Barker, D. J. P., Osmond, C., Goldings, J., Kuh, D. and Wadsworth, M. E. J. (1989a). Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br.Med. J., 298, 564-7.
7. Barker, D. J. P., Winter, P. D., Osmond, C., Margetts, B. and Simmonds, S. J. (1989b).Weight in infancy and death from ischaemic heart disease. Lancet, ii, 577-80.
8. Barker, D. J. P., Bull, A. R., Osmond, C. and Simmonds, S. J. (1990). Fetal and placental size and risk of hypertension in adult life. Br.Med. J., 301, 259-63.
9. Barker, D. J. P., Gluckman, P. D., Godfrey, K. M. et al. (1993a). Fetal nutrition and cardiovascular disease in adult life. Lancet, 341, 938-41.
10. Barker, D. J. P., Hales, C. N., Fall, C. H. D. et al. (1993b). Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia, 36, 62-7.
11. Bavdekar, A., Yajnik, C. S., Fall, C. H. et al. (1999). Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes, 48(12), 2422-9.
12. Beitens, I. Z., Bayard, F., Ances, I. G., Kowarski, A. and Migeon, C. J. (1973). The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr. Res., 7, 509-19.
13. Benediktsson, R., Lindsay, R., Noble, J., Seckl, J. R. and Edwards, C. R. W. (1993). Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet, 341, 339-41.
14. Benediktsson, R., Brennand, J., Tibi, L. et al. (1995). Fetal osteocalcin levels are related to placental 11_-hydroxysteroid dehydrogenase activity. Clin. Endocrinol., 42, 551-5.
15. Benediktsson, R., Calder, A. A., Edwards, C. R. W. and Seckl, J. R. (1997). Placental 11_-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin. Endocrinol., 46, 161-6.
16. Berry, L. M., Polk, D. H., Ikegami, M. et al. (1997). Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am. J. Physiol. Regul. Integr. Comp. Physiol., 41, R1972-9.
17. Bertram, C., Trowern, A. R., Copin, N., Jackson, A. A. and Whorwood, C. B. (2001). The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology, 142(7), 2841-53.
18. Bian, X. P., Seidler, F. J. and Slotkin, T. A. (1992). Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to _-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J. Develop. Physiol., 17, 289-97.
19. Bian, X. P., Seidler, F. J. and Slotkin, T. A. (1993). Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology, 47, 109-17.
20. Blondeau, B., Lesage, J., Czernichow, P., Dupouy, J. P. and Breant, B. (2001). Glucocorticoids impair fetal beta-cell development in rats. Am. J. Physiol. Endocrinol.Metab., 281(3), E592-9.
21. Bloom, S. L., Sheffield, J. S., McIntire, D. D. and Leveno, K. J. (2001). Antenatal dexamethasone and decreased birth weight. Obstetr. Gynecol., 97(4), 485-90.
22. Bohn, M. C. (1980). Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience, 5, 2003-12.
23. Bohn, M. C. and Lauder, J. M. (1978). The effects of neonatal hydrocortisone on rat cerebellar development: an autoradiographic and light microscopic study. Develop. Neurosci., 1, 250-66.
24. Bohn, M. C. and Lauder, J. M. (1980). Cerebellar granule cell genesis in hydrocortisone-treated rat. Develop. Neurosci., 3, 81-9.
25. Bremner, J. D., Randall, P., Scott, T. M. et al. (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder [comment]. Am. J. Psychiatr., 152(7), 973-81.
26. Brocklehurst, P., Gates, S., McKenzie-McHarg, K., Alfirevic, Z. and Chamberlain, G. (1999). Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK [comment]. Br. J. Obstetr. Gynaecol., 106(9), 977-9.
27. Brown, R. W., Diaz, R., Robson, A. C. et al. (1996a). The ontogeny of 11_-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology, 137, 794-7.
28. Brown, R. W., Kotolevtsev, Y., Leckie, C. et al. (1996b). Isolation and cloning of human placental 11_-hydroxysteroid dehydrogenase-2 cDNA. Biochem. J., 313, 1007-17.
29. Canlon, B., Erichsen, S., Nemlander, E. et al. (2003). Alterations in the intrauterine environment by glucocorticoids modifies the development programme of the auditory system. Eur. J. Neurosci., 17(10), 2035-41.
30. Catalani, A., Marinelli, M., Scaccianoce, S. et al. (1993). Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res., 624, 209-15.
31. Cetin, I., Morpurgo, P. S., Radaelli, T. et al. (2000). Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr. Res., 48(5), 646-51.
32. Chen, X., Lin, J., Hausman, D. B. et al. (2000). Alterations in fetal adipose tissue leptin expression correlate with the development of adipose tissue. Biol. Neonate, 78(1), 41-7.
33. Clark, P. M., Hindmarsh, P. C., Shiell, A. W. et al. (1996). Size at birth and adrenocortical function in childhood. Clin. Endocrinol., 45(6), 721-6.
34. Cleasby, M. E., Kelly, P. A. T., Walker, B. R. and Seckl, J. R. (2003a). Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology, 144(3), 999-1007.
35. Cleasby, M. E., Livingstone, D. E. W., Nyirenda, M. J., Seckl, J. R. and Walker, B. R. (2003b). Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? Eur. J. Endocrinol., 148(1), 129-38.
36. Cole, T. J. (1995). Cloning of the mouse 11beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology, 136, 4693-6.
37. Cole, T. J., Blendy, J. A., Monaghan, A. P. et al. (1995). Molecular genetic analysis of glucocorticoid signalling during mouse development. Steroids, 60(1), 93-6.
38. Combs, T. P., Berg, A. H., Rajala, M. W. et al. (2003). Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.Diabetes, 52, 268-76.
39. Cratty, M. S., Ward, H. E., Johnson, E. A., Azzaro, A. J. and Birkle, D. L. (1995). Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces. Brain Res., 675(1-2), 297-302.
40. Crowley, P. (2000). Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews (2): CD000065.
41. Curhan, G. C., Chertow, G. M., Willett, W. C. et al. (1996a). Birth-weight and adult hypertension and obesity in women. Circulation, 94, 1310-15.
42. Curhan, G. C., Willett, W. C., Rimm, E. B. et al. (1996b). Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation, 94, 3246-50.
43. Dave-Sharma, S., Wilson, R. C., Harbison, M. D. et al. (1998). Extensive personal experience-examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol.Metab., 83, 2244-54.
44. Davis, E. C., Popper, P. and Gorski, R. A. (1996). The role of apoptosis in sexual differentiation of the rat sexually dimorphic nucleus of the preoptic area. Brain Res., 734(1-2), 10-18.
45. Day, J. C., Koehl, M., Deroche, V., Le Moal, M. and Maccari, S. (1998). Prenatal stress enhances stress-and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. J. Neurosci., 18(5), 1886-92.
46. Dean, F. and Matthews, S. G. (1999).Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res., 846(2), 253-9.
47. Dean, F., Yu, C., Lingas, R. I. and Matthews, S. G. (2001). Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs. Neuroendocrinology, 73(3), 194-202.
48. Diaz, R., Ogren, S. O., Blum, M. and Fuxe, K. (1995). Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience, 66, 467-73.
49. Diaz, R., Fuxe, K. and Ogren, S. O. (1997). Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience, 81, 129-40.
50. Diaz, R., Brown, R. W. and Seckl, J. R. (1998). Ontogeny of mRNAs encoding glucocorticoid and mineralocorticoid receptors and 11_-hydroxysteroid dehydrogenases in prenatal rat brain development reveal complex control of glucocorticoid action. J. Neurosci., 18, 2570-80.
51. Diorio, J., Francis, D., Walker, M., Steverman, A. and Meaney, M. J. (1996). Postnatal handling induces changes in the hippocampal expression of cyclic nucleotide-dependent response element binding proteins in the rat. Soc. Neurosci. Abstr., 22, 486-7.
52. Docherty, C., Kalmar-Nagy, J., Engelen, M. and Nathanielz, P. J. (2001). Effect of in vivo infusion of dexamethasone at 0.75 gestation on responses to endothelin-1 in isolated fetal ovine resistance arteries. Am. J. Physiol., 281, R261-8.
53. Dodic, M., May, C. N., Wintour, E. M. and Coghlan, J. P. (1998). An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci., 94, 149-55.
54. Dodic, M., Peers, A., Coghlan, J. et al. (1999). Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin. Sci., 97, 103-9.
55. Dodic, M., Baird, R., Hantzis, V. et al. (2001). Organs/systems potentially involved in one model of programmed hypertension in sheep. Clin. Exp. Pharmacol. Physiol., 28(11), 952-6.
56. Dodic, M., Hantzis, V., Duncan, J. et al. (2002a). Programming effects of short prenatal exposure to cortisol. FASEB J., 16(9), 1017-26.
57. Dodic, M., Moritz, K., Koukoulas, I. and Wintour, E. M. (2002b). Programmed hypertension: kidney, brain or both? Trend. Endocrinol.Metab., 13(9), 403-8.
58. Dodic, M., Peers, A., Moritz, K., Hantzis, V. and Wintour, E. M. (2002c). No evidence for HPA reset in adult sheep with high blood pressure due to short prenatal exposure to dexamethasone. Am. J. Physiol. Regul. Integr. Comp. Physiol., 282(2), R343-50.
59. Doyle, L. W., Ford, G. W., Davis, N. M. and Callanan, C. (2000).Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci., 98(2), 137-42.
60. Dunger, D., Ong, K., Huxtable, S. et al. (1998). Association of the INS VNTR with size at birth. Nat. Genet., 19, 1061-4036.
61. Dunlop, S. A., Archer, M. A., Quinlivan, J. A., Beazley, L. D. and Newnham, J. P. (1997). Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J.Matern. Fetal Med., 6(6), 309-13.
62. Dunn, A. J. and Berridge, C. W. (1990). Physiological and behavioral responses to corticotropinreleasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res.-Brain Res. Rev., 15(2), 71-100.
63. Duong, D. T., Waltner-Law, M. E., Sears, R., Sealy, L. and Granner, D. K. (2002). Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem., 277(35), 32234-42.
64. Edwards, C. R. W., Benediktsson, R., Lindsay, R. and Seckl, J. R. (1993). Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension? Lancet, 341, 355-7.
65. Encio, I. J. and Detera-Wadleigh, S. D. (1991). The genomic structure of the human glucocorticoid receptor. J. Biol. Chem., 266(11), 7182-8.
66. Fall, C. H. D., Osmond, C., Barker, D. J. P. et al. (1995). Fetal and infant growth and cardiovascular risk factors in women. Br.Med. J., 310, 428-32.
67. Feldman, S. and Weidenfield, J. (1998). The excitatory effects of the amygdala on hypothalamopituitary-adrenocorticol responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res. Bull., 45, 389-93.
68. Forest, M. G., David, M. and Morel, Y. (1993). Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J. Steroid Biochem.Mol. Biol., 45(1-3), 75-82.
69. Forhead, A. J., Thomas, L., Crabtree, J. et al. (2002). Plasma leptin concentration in fetal sheep during late gestation: ontogeny and effect of glucocorticoids. Endocrinology, 143(4), 1166-73.
70. Forsen, T., Eriksson, J. G., Tuomilehto, J. et al. (1997).Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. Br.Med. J., 315, 837-40.
71. Frayling, T. M. and Hattersley, A. T. (2001). The role of genetic susceptibility in the association of low birth weight with type 2 diabetes. Br.Med. Bull., 60, 89-101.
72. Frayling, T. M., Hattersley, A. T., McCarthy, A. et al. (2002). A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes, 51(7), 2313-16.
73. French, N. P., Hagan, R., Evans, S., Godfrey, M. and Newnham, J. P. (1998). Repeated antenatal corticosteroids: behaviour outcomes in a regional population of very preterm infants. Pediatr. Res., 43, 214 (abstract no. 1252).
74. French, N. P., Hagan, R., Evans, S. F., Godfrey, M. and Newnham, J. P. (1999). Repeated antenatal corticosteroids: size at birth and subsequent development. Am. J. Obstetr. Gynecol., 180(1 Pt 1), 114-21.
75. Fumagalli, F., Jones, S. R., Caron, M. G., Seidler, F. J. and Slotkin, T. A. (1996). Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res., 719, 225-8.
76. Fuxe, K., Wikstrom, A.-C., Okret, S. et al. (1985). Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology, 117, 1803-12.
77. Gale, C. R., Martyn, C. N., Kellingray, S., Eastell, R. and Cooper, C. (2001). Intrauterine programming of adult body composition. J. Clin. Endocrinol.Metab., 86(1), 267-72.
78. Gandelman, R. and Rosenthal, C. (1981). Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice. Teratology, 24(3), 293-301.
79. Garofano, A., Czernichow, P. and Breant, B. (1997). In utero undernutrition impairs rat beta-cell development. Diabetologia, 40(10), 1231-4.
80. Garofano, A., Czernichow, P. and Breant, B. (1998). Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia, 41(9), 1114-20.
81. Gatford, K. L., Wintour, E. M., de Blasio, M. J., Owens, J. A. and Dodic, M. (2000). Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin. Sci., 98, 553-60.
82. Geary, M., Herschkovitz, R., Pringle, P. J., Rodeck, C. H. and Hindmarsh, P. C. (1999). Ontogeny of serum leptin concentrations in the human. Clin. Endocrinol., 51(2), 189-92.
83. Goland, R. S., Jozak, S., Warren, W. B. et al. (1993). Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab., 77, 1174-9.
84. Goland, R. S., Tropper, P. J., Warren, W. B. et al. (1995).Concentrations of corticotropin-releasing hormone in the umbilical cord blood of pregnancies complicated by preeclampsia. Reprod. Fert. Develop., 7, 1227-30.
85. Gould, E., Woolley, C. S., Cameron, H. A., Daniels, D. C. and McEwen, B. S. (1991a). Adrenal steroids regulate postnatal development in the rat dentate gyrus. II. Effects of glucocorticoids on cell birth. J. Comp. Neurol., 313, 486-93.
86. Gould, E., Woolley, C. S. and McEwen, B. S. (1991b). Adrenal steroids regulate postnatal development in the rat dentate gyrus. I. Effects of glucocorticoids on cell death. J. Comp. Neurol., 313, 479-85.
87. Gunberg, D. L. (1957). Some effects of exogenous hydrocortisone on pregnancy in the rat. Anat. Res., 129, 133-53.
88. Gustafsson, J.-A., Mode, A., Norstedt, G. and Skett, P. (1983). Sex steroid-induced changes in hepatic enzymes. Annu. Rev. Physiol., 45, 51-60.
89. Hattersley, A., Beards, F., Ballantyne, E. et al. (1998). Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat. Genet., 19, 268-70.
90. Hawkins, P., Steyn, C., McGarrigle, H. H. et al. (2000). Cardiovascular and hypothalamic-pituitary-adrenal axis development in late gestation fetal sheep and young lambs following modest maternal nutrient restriction in early gestation. Reprod. Fert.Develop., 12(7-8), 443-56.
91. Herman, J. P., Patel, P. D., Akil, H. and Watson, S. J. (1989). Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat.Mol. Endocrinol., 3(11), 1886-94.
92. Hill, D. J. and Duvillie, B. (2000). Pancreatic development and adult diabetes. Pediatr. Res., 48(3), 269-74.
93. Hoggard, N., Hunter, L., Lea, R. G., Trayhurn, P. and Mercer, J. G. (2000). Ontogeny of the expression of leptin and its receptor in the murine fetus and placenta.Br. J. Nutr., 83(3), 317-26.
94. Holmes, M. C., Welberg, L. A. and Seckl, J. R. (2002). Early life programming of the brain by glucocorticoids. Fifth International Congress of Neuroendocrinology, Bristol, UK. September: S57.
95. Holson, R. R., Gough, B., Sullivan, P., Badger, T. and Sheehan, D. M. (1995). Prenatal dexamethasone or stress but not ACTH or corticosterone alter sexual behavior in male rats. Neurotoxicol. Teratol., 17, 393-401.
96. Hsu, D., Chen, F., Takahashi, L. and Kalin, N. (1998). Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res., 788, 305-10.
97. Hu, E., Liang, P. and Spiegelman, B. M. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem., 271(18), 10697-703.
98. Huang, W. L., Beazley, L. D., Quinlivan, J. A. et al. (1999). Effect of corticosteroids on brain growth in fetal sheep. Obstetr. Gynecol., 94(2), 213-18.
99. Huang, W. L., Harper, C. G., Evans, S. F., Newnham, J. P. and Dunlop, S. A. (2001a). Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int. J. Develop. Neurosci., 19(5), 487-93.
100. Huang, W. L., Harper, C. G., Evans, S. F., Newnham, J. P. and Dunlop, S. A. (2001b). Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int. J. Develop. Neurosci., 19(4), 415-25.
101. Huxley, R. R., Shiell, A. W. and Law, C. M. (2000). The role of size at birth and postnatal catchup growth in determining systolic blood pressure: a systematic review of the literature. J. Hypertens., 18(7), 815-31.
102. Huxley, R. R., Neil, A. and Collins, R. (2002). Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet, 360(9334), 659-65.
103. Ikegami, M., Jobe, A. H., Newnham J. et al. (1997).Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am. J. Resp. Crit. Care Med., 156(1), 178-84.
104. Irving, R. J., Belton, N. R., Elton, R. A. and Walker, B. R. (2000).Adult cardiovascular risk factors in premature babies. Lancet, 355, 2135-6.
105. Jacobson, L. and Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocr. Rev., 12, 118-34.
106. Jamieson, P. M., Chapman, K. E., Edwards, C. R. W. and Seckl, J. R. (1995). 11_-hydroxysteroid dehydrogenase is an exclusive 11_-reductase in primary cultured rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology, 136, 4754-61.
107. Jamieson, P. M., Chapman, K. E. and Seckl, J. R. (1999). Tissue-and temporal-specific regulation of 11_-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. J. Steroid Biochem. Mol. Biol., 68, 245-50.
108. Jamieson, P. M., Chapman, K. E., Walker, B. R. and Seckl, J. R. (2000). 11_-hydroxysteroid dehydrogenase type 1 is a predominant 11_-reductase in the intact perfused rat liver. J. Endocrinol., 165, 685-92.
109. Jaquet, D., Leger, J., Levy-Marchal, C., Oury, J. F. and Czernichow, P. (1998). Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. J. Clin. Endocrinol.Metab., 83(4), 1243-6.
110. Jaquet, D., Tregouet, D. A., Godefroy, T. et al. (2002). Combined effects of genetic and environmental factors on insulin resistance associated with reduced fetal growth. Diabetes, 51(12), 3473-8.
111. Jensen, E. C., Gallaher, B. W., Breier, B. H. and Harding, J. E. (2002). The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep. J. Endocrinol., 174(1), 27-36.
112. Kari, M. A., Hallman, M., Eronen, M. et al. (1994). Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics, 93, 730-6.
113. Kay, H. H., Bird, I. M., Coe, C. L. and Dudley, D. J. (2000). Antenatal steroid treatment and adverse fetal effects:What is the evidence? J. Soc. Gynecol. Invest., 7(5), 269-78.
114. Keightley, M.-C. and Fuller, P. J. (1994). Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity.Mol. Endocrinol., 8, 431-9.
115. King, L. B., Vacchio, M. S., Dixon, K. et al. (1995). A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity, 3(5), 647-56.
116. Kinnunen, A. K., Koenig, J. I. and Bilbe, G. (2003). Repeated variable prenatal stress alters preand postsynaptic gene expression in the rat frontal pole. J. Neurochem., 86(3), 736-48.
117. Kitraki, E., Kittas, C. and Stylianopoulou, F. (1997). Glucocorticoid receptor gene expression during rat embryogenesis. An in situ hybridization study. Differentiation, 62, 21-31.
118. Klemcke, H. G. (1995). Placental metabolism of cortisol at mid-and late gestation in swine. Biol. Reprod., 53, 1293-301.
119. Koenen, S. V., Mecenas, C. A., Smith, G. S., Jenkins, S. and Nathanielsz, P. W. (2002). Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am. J. Obstetr. Gynecol., 186(4), 812-17.
120. Koenig, J. I., Kirkpatrick, B. and Lee, P. (2002). Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology, 27(2), 309-18.
121. Koistinen, H. A., Koivisto, V. A., Andersson, S. et al. (1997). Leptin concentration in cord blood correlates with intrauterine growth. J. Clin. Endocrinol.Metab., 82(10), 3328-30.
122. Korte, S. M. (2001). Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev., 25(2), 117-42.
123. Kotelevtsev, Y., Holmes, M. C., Burchell, A. et al. (1997). 11_-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress. Proc. Natl. Acad. Sci. USA, 94, 14924-9.
124. Kotelevtsev, Y., Brown, R. W., Fleming, S. et al. (1999). Hypertension in mice lacking 11_-hydroxysteroid dehydrogenase type 2. J. Clin. Invest., 103, 683-9.
125. Langdown, M. L., Holness, M. J. and Sugden, M. C. (2001a). Early growth retardation induced by excessive exposure to glucocorticoids in utero selectively increases cardiac GLUT1 protein expression and Akt/protein kinase B activity in adulthood. J. Endocrinol., 169(1), 11-22.
126. Langdown, M. L., Smith, N. D., Sugden, M. C. and Holness, M. J. (2001b). Excessive glucocorticoid exposure during late intrauterine development modulates the expression of cardiac uncoupling proteins in adult hypertensive male offspring. Pflug. Arch. Eur. J. Physiol., 442(2), 248-55.
127. Langdown, M. L., Holness, M. J. and Sugden, M. C. (2003). Effects of prenatal glucocorticoid exposure on cardiac calreticulin and calsequestrin protein expression during early development and in adulthood. Biochem. J., 371, 61-9.
128. Langley-Evans, S. C. (1997).Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertens., 15, 537-44.
129. Langley-Evans, S. C., Gardner, D. S. and Jackson, A. A. (1996a).Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J. Nutr., 126, 1578-85.
130. Langley-Evans, S. C., Philips, G., Benediktsson, R. et al. (1996b).Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta, 17, 169-72.
131. Laplante, P., Diorio, J. and Meaney, M. J. (2002). Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Res.-Develop. Brain Res. 139, 199-203.
132. Law, C. M., Shiell, A.W., Newsome, C. A. et al. (2002). Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation, 105(9), 1088-92.
133. Leon, D. A., Koupilova, I., Lithell, H. O. et al. (1996). Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. Br.Med. J., 312, 401-6.
134. Lepercq, J., Challier, J. C., Guerre-Millo, M. et al. (2001). Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J. Clin. Endocrinol.Metab., 86(6), 2409-13.
135. Lesage, J., Blondeau, B., Grino, M., Breant, B. and Dupouy, J. P. (2001). Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology, 142(5), 1692-702.
136. Levine, S. (1957). Infantile experience and resistance to physiological stress. Science, 126, 405-6.
137. Levine, S. (1962). Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science, 135, 795-6.
138. Levine, R. S., Hennekens, C. H. and Jesse, M. J. (1994). Blood pressure in prospective population based cohort of newborn and infant twins. Br.Med. J., 308, 298-302.
139. Levitt, N., Lindsay, R. S., Holmes, M. C. and Seckl, J. R. (1996). Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology, 64, 412-18.
140. Levitt, N. S., Lambert, E. V., Woods, D. et al. (2000). Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young South African adults: early programming of cortisol axis. J. Clin. Endocrinol.Metab., 85(12), 4611-18.
141. Lindsay, R. S., Lindsay, R. M., Edwards, C. R. W. and Seckl, J. R. (1996a). Inhibition of 11_-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension, 27, 1200-4.
142. Lindsay, R. S., Lindsay, R. M., Waddell, B. and Seckl, J. R. (1996b). Programming of glucose tolerance in the rat: role of placental 11_-hydroxysteroid dehydrogenase.Diabetologia, 39, 1299-305.
143. Lindsay, R. S., Funahashi, T., Hanson, R. L. et al. (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 360(9326), 57-8.
144. Lindsay, R., Walker, J., Havel, P. et al. (2003). Adiponectin is present in cord blood but is unrelated to leptin and birth weight. Diabetes Care, 26, 2244-8.
145. Lithell, H. O., McKeigue, P. M., Berglund, L. et al. (1996). Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br.Med. J., 312, 406-10.
146. Liu, D., Diorio, J., Tannenbaum, B. et al. (1997). Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science, 277, 1659-62.
147. Liu, L., Li, A. and Matthews, S. G. (2001).Maternal glucocorticoid treatment programs HPA regulation in adult offspring: sex-specific effects. Am. J. Physiol. Endocrinol.Metab., 280(5), E729-39.
148. Lopez-Bernal, A., Flint, A. P. F., Anderson, A. B. M. and Turnbull, A. C. (1980). 11_-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J. Steroid Biochem., 13, 1081-7.
149. Lopez Bernal, A. and Craft, I. L. (1981). Corticosteroid metabolism in vitro by human placenta, foetal membranes and decidua in early and late gestation. Placenta, 2, 279-85.
150. MacArthur, B. A., Howie, R. N., Dezoete, J. A. and Elkins, J. (1982). School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics, 70(1), 99-105.
151. Maccari, S., Piazza, P. V., Kabbaj, M. et al. (1995). Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J. Neurosci., 15, 110-16.
152. Makino, S., Gold, P. W. and Schulkin, J. (1994). Effects of corticosterone on CRH mRNA and content in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Research, 640, 105-112.
153. Matthews, S. G. (1998). Dynamic changes in glucocorticoid and mineralocorticoid receptor mRNA in the developing guinea pig brain. Brain Res.-Develop. Brain Res., 107(1), 123-32.
154. Matthews, S. G. (2000). Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res., 47(3), 291-300.
155. Matthews, S. G. (2002). Early programming of the hypothalamo-pituitary-adrenal axis. Trend. Endocrinol.Metab., 130, 373-80.
156. McCormick, C. M., Smythe, J. W., Sharma, S. and Meaney, M. J. (1995). Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Develop. Brain Res., 84, 55-61.
157. McCormick, J. A., Lyons, V., Jacobson, M. D. et al. (2000). 5 -heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events.Mol. Endocrinol., 14(4), 506-17.
158. McTernan, C. L., Draper, N., Nicholson, H. et al. (2001). Reduced placental 11 beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol.Metab., 86(10), 4979-83.
159. Meaney, M. J., Aitken, D. H., van Berkel, C., Bhatnagar, S. and Sapolsky, R. M. (1988). Effect of neonatal handling on age-related impairments associated with the hippocampus. Science, 239, 766-8.
160. Meaney, M. J., Aitken, D. H., Viau, V., Sharma, S. and Sarrieau, A. (1989). Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology, 50, 597-604.
161. Meaney, M. J., Aitken, D. H., Sharma, S. and Viau, V. (1992). Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticosteroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology, 55, 204-13.
162. Meaney, M. J., Diorio, J., Francis, D. et al. (1996). Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Develop. Neurosci., 18, 49-72.
163. Meaney, M. J., Diorio, J., Francis, D. et al. (2000). Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. J. Neurosci., 20(10), 3926-35.
164. Mercado, A. B., Wilson, R. C., Cheng, K. C., Wei, J. Q. and New, M. I. (1995a). Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol.Metab., 80(7), 2014-20.
165. Mercado, A. B., Wilson, R. C., Cheng, K. C., Wei, J. Q. and New, M. I. (1995b). Prenatal treatment and diagnosis of congential adrenal hyperlasia owing to 21-hydroxylase deficiency. J. Clin. Endocrinol.Metab., 80, 2014-20.
166. Meyer, J. S. (1983). Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp. Neurol., 82, 432-46.
167. Mitchell, J. B., Rowe, W., Boksa, P. and Meaney, M. J. (1990). Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J. Neurosci., 10(6), 1745-52.
168. Mitchell, J. B., Betito, K., Rowe, W., Boksa, P. and Meaney, M. J. (1992). Serotonergic regulation of type II corticosteroid receptor binding in hippocampal cell cultures: evidence for the importance of serotonin-induced changes in cAMP levels. Neuroscience, 48(3), 631-9.
169. Molnar, J., Nijland, M. J. M., Howe, D. C. and Nathanielsz, P. W. (2002). Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol., 283(3), R561-7.
170. Molnar, J., Howe, D. C., Nijland, M. J. M. and Nathanielsz, P. W. (2003). Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J. Physiol. London, 547(1), 61-6.
171. Moore, V. M., Miller, A. G., Boulton, T. J. C. et al. (1996). Placental weight, birth measurements, and blood pressure at age 8 years. Arch. Dis. Child., 74, 538-41.
172. Moritz, K. M., Johnson, K., Douglas-Denton, R., Wintour, E. M. and Dodic, M. (2002).Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology, 143(11), 4455-63.
173. Moss, T. J., Sloboda, D. M., Gurrin, L. C. et al. (2001). Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am. J. Physiol. Regul. Integr. Comp. Physiol., 281(3), R960-70.
174. Mostyn, A., Keisler, D. H., Webb, R., Stephenson, T. and Symonds, M. E. (2001). The role of leptin in the transition from fetus to neonate. Proc. Nutr. Soc., 60(2), 187-94.
175. Mostyn, A., Pearce, S., Budge, H. et al. (2003). Influence of cortisol on adipose tissue development in the fetal sheep during late gestation. J. Endocrinol., 176, 23-30.
176. Muneoka, K., Mikuni, M., Ogawa, T. et al. (1997). Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Am. J. Physiol., 273(5 Pt 2), R1669-75.
177. Murphy, V. E., Zakar, T., Smith, R. et al. (2002). Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J. Clin. Endocrinol.Metab., 87(4), 1660-8.
178. Newnham, J. P. and Moss, T. J. (2001). Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin. Neonatol., 6(4), 285-92.
179. Newnham, J. P., Evans, S. F., Godfrey, M. et al. (1999).Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J.Matern. Fetal Med., 8(3), 81-7.
180. Nyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A. and Seckl, J. R. (1998). Glucocorticoid exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest., 101, 2174-81.
181. Nyirenda, M. J., Welberg, L. A. M. and Seckl, J. R. (2001). Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence? J. Endocrinol., 170(3), 653-60.
182. O'Donnell, D., Larocque, S., Seckl, J. R. and Meaney, M. J. (1994). Postnatal handling alters glucocorticoid, but not mineralocorticoid messenger RNA expression in the hippocampus of adult rats. Brain Res.-Mol. Brain Res., 26(1-2), 242-8.
183. Ong, K. K., Ahmed, M. L., Sherriff, A. et al. (1999). Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans. ALSPAC Study Team, Avon Longitudinal Study of Pregnancy and Childhood. J. Clin. Endocrinol.Metab., 84(3), 1145-8.
184. Ortiz, L. A., Quan, A., Weinberg, A. and Baum, M. (2001). Effect of prenatal dexamethasone on rat renal development. Kidney Int., 59(5), 1663-9.
185. Osmond, C., Barker, D. J. P., Winter, P. D., Fall, C. H. D. and Simmonds, S. J. (1993). Early growth and death from cardiovascular disease in women. Br.Med. J., 307, 1524-7.
186. Pepin, M. C., Pothier, F. and Barden, N. (1992). Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature, 355(6362), 725-8.
187. Phillips, D. I., Barker, D. J., Fall, C. H. et al. (1998). Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol.Metab., 83(3), 757-60.
188. Phillips, D. I., Walker, B. R., Reynolds, R. M. et al. (2000). Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension, 35(6), 1301-6.
189. Reinisch, J. M., Simon, N. G. and Karwo, W. G. et al. (1978). Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science, 202, 436-8.
190. Reul, J. M. H. M. and de Kloet, E. R. (1985). Two receptor systems for corticosterone in rat brain: microdissection and differential occupation. Endocrinology, 117, 2505-11.
191. Reynolds, R. M., Walker, B. R., Syddall, H. E. et al. (2001). Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab., 86(1), 245-50.
192. RichEdwards, J. W., Stampfer, M. J., Manson, J. E. et al. (1997). Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br.Med. J., 315, 396-400.
193. Robson, A. C., Leckie, C., Seckl, J. R. and Holmes, M. C. (1998). Expression of 11_-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain.Mol. Brain Res., 61, 1-10.
194. Rogerson, F. M., Kayes, K. and White, P. C. (1996). No correlation in human placenta between activity or mRNA for the K (type 2) isozyme of 11_-hydroxysteroid dehydrogenase and fetal or placental weight. Tenth International Congress of Endocrinology Abstracts (P1-231), 193.
195. Rogerson, F. M., Kayes, K. M. and White, P. C. (1997). Variation in placental type 2 11betahydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol. Cell. Endocrinol., 128, 103-9.
196. Rosella, G., Zajac, J. D., Kaczmarczyk, S. J., Andrikopoulos, S. and Proietto, J. (1993). Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene.Mol. Endocrinol., 7(11), 1456-62.
197. Saegusa, H., Nakagawa, Y., Liu, Y. J. and Ohzeki, T. (1999). Influence of placental 11 betahydroxysteroid dehydrogenase (11 beta-HSD) inhibition on glucose metabolism and 11 beta-HSD regulation in adult offspring of rats.Metab. Clin. Exp., 48(12), 1584-8.
198. Sapolsky, R. M. (1999). Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp. Gerontol., 34(6), 721-32.
199. Schubring, C., Kiess, W., Englaro, P. et al. (1997). Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J. Clin. Endocrinol.Metab., 82(5), 1480-3.
200. Seckl, J. R. (1994). Glucocorticoids and small babies. Quart. J.Med., 87, 259-62.
201. Seckl, J. R. (1998). Physiologic programming of the fetus. Clin. Perinatol., 25, 939-64.
202. Seckl, J. R. and Miller, W. L. (1997). How safe is long-term prenatal glucocorticoid treatment? J. Am.Med. Assoc., 277, 1077-9.
203. Seckl, J. R. and Walker, B. R. (2001). 11_-hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-6.
204. Seckl, J. R., Dickson, K. L., Yates, C. and Fink, G. (1991). Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res., 561, 332-7.
205. Shams, M., Kilby, M. D., Somerset, D. A. et al. (1998). 11beta hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth retardation. Hum. Reprod., 13, 799-804.
206. Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G. and Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA, 93, 3908-13.
207. Shen, C.-N., Seckl, J., Slack, J. and Tosh, D. (2003). Glucocorticoids suppress beta cell development and induce hepatic metaplasia in embryonic pancreas. Biochem. J., 375, 41-50.
208. Simerly, R. B. (2002).Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Annu. Rev. Neurosci., 25, 507-36.
209. Slieker, L. J., Sloop, K. W., Surface, P. L. et al. (1996). Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem., 271(10), 5301-4.
210. Sloboda, D. M., Moss, T. J., Gurrin, L. C., Newnham, J. P. and Challis, J. R. (2002a). The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function. J. Endocrinol., 172(1), 71-81.
211. Sloboda, D. M., Newnham, J. P. and Challis, J. R. G. (2002b). Repeated maternal glucocorticoid administration and the developing liver in fetal sheep. J. Endocrinol., 175, 535-43.
212. Slotkin, T. A., Barnes, G. A., McCook, E. C. and Seidler, F. J. (1996a). Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Res.-Develop. Brain Res., 93(1-2), 155-61.
213. Slotkin, T. A., Barnes, G. A., McCook, E. C. and Seidler, F. J. (1996b). Programming of brainstem serotonin transporter development by prenatal glucocorticoids.Develop. Brain Res., 93, 155-61.
214. Smith, J. T. and Waddell, B. J. (2002). Leptin receptor expression in the rat placenta: changes in Ob-Ra, Ob-Rb, and Ob-Re with gestational age and suppression by glucocorticoids. Biol. Reprod., 67(4), 1204-10.
215. Smythe, J. W., Rowe, W. B. and Meaney, M. J. (1994).Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Brain Res.-Develop. Brain Res., 80(1-2), 183-9.
216. Stein, M. B., Koverola, C., Hanna, C., Torchia, M. G. and McClarty, B. (1997).Hippocampal volume in women victimized by childhood sexual abuse. Psychol.Med., 27(4), 951-9.
217. Stewart, P. M., Corrie, J. E. T., Shackleton, C. H. L. and Edwards, C. R. W. (1988). Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J. Clin. Invest., 82, 340-9.
218. Stewart, P. M., Murry, B. A. and Mason, J. I. (1994). Type 2 11_-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol.Metab., 78, 1529-32.
219. Stewart, P. M., Rogerson, F. M. and Mason, J. I. (1995). Type 2 11_-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab., 80, 885-90.
220. Stocker, C., O'Dowd, J., Morton, N. et al. (2004).Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation. Int. J. Obesity, 28, 129-36.
221. Sugden, M. C., Langdown, M. L., Munns, M. J. and Holness, M. J. (2001). Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur. J. Endocrinol., 145(4), 529-39.
222. Sun, K., Yang, K. and Challis, J. R. G. (1997). Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J. Clin. Endocrinol. Metab., 82, 300-5.
223. Tangalakis, K., Lumbers, E. R., Moritz, K. M., Towstoless, M. K. and Wintour, E. M. (1992). Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp. Physiol., 77, 709-17.
224. Thomas, L., Wallace, J. M., Aitken, R. P. et al. (2001). Circulating leptin during ovine pregnancy in relation to maternal nutrition, body composition and pregnancy outcome. J. Endocrinol., 169(3), 465-76.
225. Thomassin, H., Flavin, M., Espinas, M. L. and Grange, T. (2001). Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J., 20(8), 1974-83.
226. Trautman, P. D., Meyer-Bahlburg, H. F., Postelnek, J. and New, M. I. (1995). Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology, 20(4), 439-49.
227. Tronche, F., Kellendonk, C., Kretz, O. et al. (1999). Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet., 23, 99-103.
228. Uno, H., Lohmiller, L., Thieme, C. et al. (1990). Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. hippocampus. Develop. Brain Res., 53, 157-67.
229. Uno, H., Eisele, S., Sakai, A. et al. (1994). Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav., 28, 336-48.
230. Vaessen, N., Heutink, P., Janssen, J. A. et al. (2001). A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.Diabetes, 50(3), 637-42.
231. Valera, A., Pujol, A., Pelegrin, M. and Bosch, F. (1994). Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA, 91(19), 9151-4.
232. Venihaki, M. A., Carrigan, P., Dikkes. et al. (2000). Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proc. Natl. Acad. Sci. USA, 97, 7336-41.
233. Voice, M., Seckl, J. R., Edwards, C. R. W. and Chapman, K. E. (1996). 11_-hydroxysteroid dehydrogenase type 1 expression in 2S-FAZA hepatoma cells is hormonally-regulated: a model for the study of hepatic corticosteroid metabolism. Biochem. J., 317, 621-5.
234. Walfisch, A., Hallak, M. and Mazor, M. (2001). Multiple courses of antenatal steroids: risks and benefits. Obstetr. Gynecol., 98(3), 491-7.
235. Ward, R. M. (1994). Pharmacologic enhancement of fetal lung maturation. Clin. Perinatol., 21, 523-42.
236. Weaver, I. C. G., Szyf, M. and Meaney, M. J. (2002). From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocr. Res., 28(4), 699.
237. Weinstock, M. (2001). Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol., 65, 427-51.
238. Weinstock, M., Matlina, E., Maor, G. I., Rosen, H. and McEwen, B. S. (1992). Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res., 595, 195-200.
239. Welberg, L. A. M. and Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol., 13, 113-28.
240. Welberg, L. A. M., Seckl, J. R. and Holmes, M. C. (2000). Inhibition of 11_-hydroxysteroid dehydrogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the offspring. Eur. J. Neurosci., 12, 1047-54.
241. Welberg, L. A. M., Seckl, J. R. and Holmes, M. C. (2001). Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience, 104, 71-9.
242. Weyer, C., Funahashi, T., Tanaka, S. et al. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 86(5), 1930-5.
243. White, P. C., Mune, T. and Agarwal, A. K. (1997). 11beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev., 18, 135-56.
244. Whitelaw, A. and Thoresen, M. (2000). Antenatal steroids and the developing brain. Arch. Dis. Child. Fetal Neonatal Edn., 83(2), F154-7.
245. Whorwood, C. B., Franklyn, J. A., Sheppard, M. C. and Stewart, P. M. (1991). Tissue localization of 11_-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J. Steroid Biochem.Mol. Biol., 41, 21-8.
246. Whorwood, C. B., Firth, K. M., Budge, H. and Symonds, M. E. (2001).Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11 beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep. Endocrinology, 142(7), 2854-64.
247. Yajnik, C. S., Fall, C. H. D., Vaidya, U. et al. (1995). Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabetic Med., 12, 330-6.
248. Yang, K., Matthews, S. G. and Challis, J. R. G. (1995). Developmental and glucocorticoid regulation of pituitary 11beta-hydroxysteroid dehydrogenase 1 gene expression in the ovine fetus and lamb. J.Mol. Endocrinol., 14, 109-16.
249. Yau, J. L., Noble, J. and Seckl, J. R. (1997a). Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin. Neuroscience, 78(1), 111-21.
250. Yau, J. L. W., Noble, J., Widdowson, J. and Seckl, J. R. (1997b). Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus.Mol. Brain Res., 45, 182-6.
251. Yuen, B. S., McMillen, I. C., Symonds, M. E. and Owens, P. C. (1999). Abundance of leptin mRNA in fetal adipose tissue is related to fetal body weight. J. Endocrinol., 163(3), R11-4.